| __timestamp | Bio-Techne Corporation | Dr. Reddy's Laboratories Limited |
|---|---|---|
| Wednesday, January 1, 2014 | 106352000 | 56369000000 |
| Thursday, January 1, 2015 | 144969000 | 62786000000 |
| Friday, January 1, 2016 | 162364000 | 62427000000 |
| Sunday, January 1, 2017 | 188462000 | 62453000000 |
| Monday, January 1, 2018 | 210850000 | 65724000000 |
| Tuesday, January 1, 2019 | 240515000 | 70421000000 |
| Wednesday, January 1, 2020 | 255497000 | 80591000000 |
| Friday, January 1, 2021 | 298182000 | 86645000000 |
| Saturday, January 1, 2022 | 349103000 | 100551000000 |
| Sunday, January 1, 2023 | 366887000 | 42907000000 |
| Monday, January 1, 2024 | 389335000 | 115557000000 |
Unleashing the power of data
In the ever-evolving landscape of pharmaceuticals and biotechnology, understanding cost dynamics is crucial. Dr. Reddy's Laboratories Limited and Bio-Techne Corporation, two giants in their respective fields, offer a fascinating study in contrasts. From 2014 to 2024, Dr. Reddy's Laboratories consistently reported a cost of revenue that dwarfed Bio-Techne's, peaking at over 115 billion in 2024. This represents a staggering 100% increase from 2014. In contrast, Bio-Techne's cost of revenue grew steadily, reaching nearly 390 million in 2024, marking a 266% rise over the same period. This disparity highlights the scale and operational differences between a pharmaceutical behemoth and a biotech innovator. As the industry continues to grow, these insights provide a window into the strategic financial maneuvers of leading companies.
Amgen Inc. vs Bio-Techne Corporation: Efficiency in Cost of Revenue Explored
Cost Insights: Breaking Down Gilead Sciences, Inc. and Bio-Techne Corporation's Expenses
Cost of Revenue Comparison: Vertex Pharmaceuticals Incorporated vs Dr. Reddy's Laboratories Limited
Cost of Revenue Trends: Takeda Pharmaceutical Company Limited vs Dr. Reddy's Laboratories Limited
United Therapeutics Corporation vs Bio-Techne Corporation: Efficiency in Cost of Revenue Explored
Cost of Revenue: Key Insights for Dr. Reddy's Laboratories Limited and Corcept Therapeutics Incorporated
Analyzing Cost of Revenue: Dr. Reddy's Laboratories Limited and Ionis Pharmaceuticals, Inc.
Cost Insights: Breaking Down Dr. Reddy's Laboratories Limited and Xenon Pharmaceuticals Inc.'s Expenses
Cost of Revenue Comparison: Dr. Reddy's Laboratories Limited vs Iovance Biotherapeutics, Inc.
Bio-Techne Corporation vs Amneal Pharmaceuticals, Inc.: Efficiency in Cost of Revenue Explored
Bio-Techne Corporation vs Geron Corporation: Efficiency in Cost of Revenue Explored
Analyzing Cost of Revenue: Bio-Techne Corporation and Viridian Therapeutics, Inc.